Unveiling the Future: Dr. Khademi’s Workshop Sheds Light on TMS Revolution

In a groundbreaking workshop at Beth Israel Medical Center, Harvard affiliated, Dr. Khademi delves into the transformative potential of Transcranial Magnetic Stimulation (TMS) in treating a spectrum of neurological disorders.

Key Takeaways:

  • Efficacy in Mental Health: TMS has showcased significant efficacy in treating major depressive and obsessive-compulsive disorders, as highlighted by a literature review from Loyola Medicine neurologist Dr. Antonio H. Iglesias.
  • Wider Neurological Applications: Beyond mental health, TMS exhibits promise in addressing common neurological conditions, including stroke, acute migraines, and dementia. The magnetic pulses alter neuronal activity, opening avenues for improved brain functionality.
  • Versatility of TMS: Dr. Iglesias emphasizes TMS’s ability to function as a stimulant, inhibitor, or both, impacting outcomes based on a patient’s neuroplasticity.
  • FDA Approval and Ongoing Studies: TMS is FDA-approved for depression and OCD, with 1,641 studies underway exploring its potential in various neurological disorders, including early dementia, acute migraines, and primary progressive aphasia.
  • TMS in Practice: Loyola Medicine is already successfully implementing TMS in treating depression and OCD, with plans to explore its potential in addressing dementia, particularly the early effects of primary progressive aphasia.

Looking Forward: Dr. Khademi envisions a future where TMS reshapes neurology across diverse areas, improving brain functionality and network connections. For cutting-edge TMS therapy tailored to your needs, contact Countryside Neurology at 727-712-1567.

Take Action: Embark on a transformative journey with TMS therapy. Contact Countryside Neurology at 727-712-1567 for expert consultation and personalized TMS solutions. Experience the future of neurology today.

#TMSatCountrysideNeurology #TMSatCSNeuro